The global retinal implants market is projected to reach USD 76.8 million by 2028, growing at a CAGR of 10.4%. Growing burden of eye diseases across the globe, development of new healthcare facilities in evolving economies and technological advancements in ophthalmology implants are some of the factors driving the growth of the global retinal implants market.
Adroit Market Research report on global Retinal implants market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global Retinal implants market have been studied in detail.
The global retinal implants market is categorized based on device type and is segmented into retina implant alpha AMS, implantable miniature telescope, Argus II, and others. The implantable miniature telescope is set to observer the highest CAGR over the forecast period.
North America dominated the market for retinal implants in 2020, while Asia Pacific is set to grow at a highest CAGR due to rising awareness regarding eye implants. Key players of the global retinal implants market include Second Sight Medical Products, Inc., VisionCare, Inc., Pixium Vision, Nano Retina and Labtician Ophthalmics, Inc.
Key segments of the global retinal implants market
Device Type Overview, 2018-2028 (USD Million)
- Retina implant alpha AMS
- Implantable miniature telescope
- Argus II
Regional Overview, 2018-2028 (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Middle East & Africa